The digital health landscape is crowded, and for early-stage companies, establishing trust is paramount. A recent discussion with Dr. Jennifer Huberty, CEO and founder of Fit Minded, highlighted a critical, often overlooked element of success: a robust, early-stage data strategy. Huberty argues that many behavioral health startups underestimate the power of the data they already possess, and how strategically leveraging that data can be a powerful driver of growth, credibility, and survival.
Huberty’s insights, shared in a recent podcast, emphasize that strong scientific backing isn’t merely a compliance checkbox, but a fundamental growth strategy. In a market increasingly saturated with digital health solutions, demonstrating scientific rigor can differentiate a company and attract both investment and users. The challenge, however, lies in building that credibility without depleting limited resources – a common struggle for startups.
The Untapped Potential of Existing Data
A core tenet of Huberty’s approach is recognizing the value inherent in the data a company already collects. Too often, this data is siloed or viewed solely through the lens of immediate product development. Huberty advocates for a broader perspective, seeing this data as a potential engine for business decisions, marketing narratives, and even peer-reviewed publications. “Many startups fail to recognize the value of the data they already possess,” she explained. This data, when analyzed effectively, can provide valuable insights into user behavior, treatment efficacy, and overall product performance.
Fit Minded, a company focused on mental fitness, exemplifies this approach. According to their website, they translate behavioral science, habit formation, and outcomes research into practical applications. Fit Minded’s success, in part, stems from a commitment to data-driven decision-making and a willingness to invest in understanding the scientific basis of their interventions.
Cost-Effective Research Strategies for Startups
Huberty outlined several cost-effective research strategies that startups can employ to build their scientific credibility. Retrospective analyses of existing data are a particularly valuable starting point. By examining historical data, companies can identify trends, patterns, and potential areas for improvement without the expense of conducting new studies. National surveys, while requiring some investment, can provide valuable insights into broader market trends and user needs.
However, Huberty cautioned against fragmented, one-off studies that lack strategic alignment. She stressed the importance of developing a cohesive research plan that supports the company’s overall business goals. “Fragmented studies are less impactful and can even be misleading,” she noted. A well-defined research strategy ensures that efforts are focused on the most critical questions and that findings are actionable.
“Traveling Science”: Making Research Actionable
Huberty introduced the concept of “traveling science,” a framework for ensuring that research findings are effectively disseminated and utilized across all departments within a company. This involves breaking down silos between research, marketing, product development, and sales, and fostering a culture of data-driven decision-making. “Traveling science” means that research insights are not confined to academic papers but are actively integrated into product roadmaps, marketing campaigns, and sales strategies.
This approach requires clear communication and collaboration between different teams. Researchers need to be able to translate complex findings into accessible language for non-scientific audiences, while marketing and sales teams need to understand how to leverage research insights to effectively communicate the value proposition of the product.
The Importance of Trust, Transparency, and Alignment
Underpinning all of Huberty’s recommendations is the importance of trust, transparency, and clear alignment with business goals. Building trust with users, investors, and the broader healthcare community requires a commitment to ethical research practices and transparent reporting of findings. Alignment with business goals ensures that research efforts are focused on the most impactful areas and that findings are directly relevant to the company’s success.
Establishing lasting research partnerships similarly requires a focus on these core principles. Huberty emphasized the need for clear communication, mutual respect, and a shared commitment to scientific rigor. Strong partnerships can provide access to valuable expertise, resources, and data, accelerating the research process and enhancing the credibility of the findings.
The Broader Context: Digital Health and Data Strategy
The need for a strong data strategy in digital health is becoming increasingly apparent. The digital health market is projected to continue its rapid growth, with a report by Statista estimating the global digital health market size at approximately 175 billion U.S. Dollars in 2023. As the market matures, competition will intensify, and companies that can demonstrate a clear commitment to scientific rigor and data-driven decision-making will be best positioned to succeed.
regulatory scrutiny of digital health products is increasing. The Food and Drug Administration (FDA) is actively developing guidance for the regulation of digital health technologies, and companies will need to demonstrate the safety and efficacy of their products to gain market access. A robust data strategy is essential for meeting these regulatory requirements.
The Role of Outcomes Rocket
The discussion with Dr. Huberty was featured on the Outcomes Rocket podcast, a platform dedicated to interviews with influential healthcare leaders. Outcomes Rocket, described as a healthcare marketing agency, provides resources for accelerating growth in the healthcare sector. The podcast, launched in September 2025, features leaders like Zain Qayyum discussing innovations in healthcare, such as eliminating waiting times through artificial intelligence.
The podcast’s focus on outcomes and data-driven marketing aligns with Huberty’s emphasis on the importance of leveraging data to demonstrate value and build trust.
Key Takeaways
- Prioritize Data from the Start: Don’t underestimate the value of the data you already collect.
- Focus on Strategic Research: Develop a cohesive research plan aligned with your business goals.
- Embrace “Traveling Science”: Ensure research findings are disseminated and utilized across all departments.
- Build Trust and Transparency: Commit to ethical research practices and transparent reporting.
The insights shared by Dr. Jennifer Huberty offer a valuable roadmap for digital health startups seeking to navigate the complexities of the market and establish a sustainable competitive advantage. By prioritizing data strategy, embracing scientific rigor, and fostering a culture of trust and transparency, these companies can position themselves for long-term success.
The ongoing evolution of digital health technologies and the increasing emphasis on data-driven healthcare will undoubtedly continue to shape the industry. Further developments in FDA guidance and the adoption of new research methodologies will be key areas to watch in the coming months.
What are your thoughts on the role of data in building trust in digital health? Share your comments below, and let’s continue the conversation.